Alvarez-Moreno, Carlos, Cassell, Jackie A, Donkor, Claudia M, Head, Michael G, Middleton, Jo, Pomat, William, Saki, Bayaki and Yirgu, Robel (2021) Long-term consequences of the misuse of ivermectin data. Lancet Infectious Diseases. ISSN 1473-3099

PDF - Accepted Version Available under License Creative Commons Attribution-NonCommercial No Derivatives. Download (134kB)

Abstract

Ivermectin is an oral anti-infective medicine that is integral to neglected tropical disease programmes. It is safe and effective for the treatment and control of lymphatic filariasis, scabies, and onchocerciasis, sometimes as part of a mass drug administration, as recognised in the WHO road map for neglected tropical diseases 2021–30. The WHO essential medicines list provides recommendations for minimum medicine needs for a basic health-care system, which includes ivermectin as an anthelmintic, antifilarial, and antiectoparasitic treatment. There has been a groundswell of opinion across several countries that ivermectin might be useful in reducing the symptoms of and mortality due to COVID-19, with many citing meta-analyses that infer positive effects; however, these conclusions appear to be unreliable.

Item Type:	Article
Additional Information:	Authors listed alphabetical order of surname, all to be recognised as equal contributions
Keywords:	Scabies, Global Health, Neglected Tropical Diseases, COVID-19, Evidence Based Medicine, Ivermectin, Medical acarology
Schools and Departments:	Brighton and Sussex Medical School > Primary Care and Public Health
SWORD Depositor:	Mx Elements Account
Depositing User:	Mx Elements Account
Date Deposited:	22 Oct 2021 07:48
Last Modified:	19 Apr 2022 01:00
URI:	http://sro.sussex.ac.uk/id/eprint/102416

View download statistics for this item

📧 Request an update